ArticleEuropean journal of nuclear medicine and molecular imaging2012

Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib.

Carsten Kobe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.